Brief: Arch Biopartners Closes Non-Brokered Private Placement
14/03/2025 20:35
March 14 (Reuters) - Arch Biopartners Inc ARCH.V: ARCH BIOPARTNERS CLOSES NON-BROKERED PRIVATE PLACEMENT Source text: ID:nGNX234rDH Further company coverage: ARCH.V ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Arch Biopartners
See all newsBrief: Arch Biopartners To Expand Phase Ii Cardiac Surgery-Associated Acute Kidney Injury Trial To The US
Brief: Arch Biopartners Closes Non-Brokered Private Placement
Brief: Arch Strengthens Its Position As A Leading Kidney Therapeutics Company With The Acquisition Of A Breakthrough Platform To Develop New Drugs Targeting Chronic Kidney Disease (Ckd)
Brief: Arch Biopartners Closes Non-Brokered Private Placement
Brief: Arch Biopartners Announces Ontario Research Ethics Board Approval To Start Phase II Trial For LSALT Peptide